Becton, Dickinson & Co. (BDX)
143.67
+0.20
(+0.14%)
USD |
NYSE |
May 18, 13:18
Becton, Dickinson Research and Development Expense (Quarterly) : 249.00M for March 31, 2026
Research and Development Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Quarterly) Benchmarks
| Abbott Laboratories | 767.00M |
| Baxter International, Inc. | 124.00M |
| Intuitive Surgical, Inc. | 361.60M |
| Boston Scientific Corp. | 516.00M |
| Insulet Corp. | 89.70M |